SCHEMBL22729243

SCHEMBL22729243

COc1ccc(C(=O)NCc2cccnc2)cc1NS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.72

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 10/20 0.72
ALDH1A1 P00352 3/20 0.66
KDM4E B2RXH2 1/20 0.66
MEN1 O00255 1/20 0.66
KMT2A Q03164 1/20 0.66
CYP1A2 P05177 2/20 0.66
CYP3A4 P08684 2/20 0.66
TSHR P16473 1/20 0.66
BLM P54132 1/20 0.66
L3MBTL1 Q9Y468 2/20 0.65
USP2 O75604 1/20 0.65
NPSR1 Q6W5P4 1/20 0.65
CYP2C19 P33261 1/20 0.64
KCNJ1 P48048 1/20 0.60
MMP13 P45452 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21246641 0.89 ALDH1A1 (0.70) NAMPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL29437164 0.89 ALDH1A1 (0.70) NAMPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL23009667 0.87 ALDH1A1 (0.68) NAMPTALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL21246542 0.87 NAMPT (0.71) NAMPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL29437169 0.87 NAMPT (0.71) NAMPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL21222746 0.87 ALDH1A1 (0.68) NAMPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL22729255 0.87 ALDH1A1 (0.68) NAMPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL21246579 0.85 NAMPT (0.72) NAMPTALDH1A1KDM4EMEN1KMT2A
Picotamide SCHEMBL4875152 0.84 CYP1A2 (0.79) NAMPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL164791 0.84 NAMPT (1.00) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391647-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2025-08-19 US disclosed
US-20230099912-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2023-03-30 US disclosed
EP-3747866-B1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INST MATERIA MEDICA CAMS (CN) 2023-03-01 EP disclosed
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-12-06 US disclosed
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-12-06 US disclosed
CN-110092743-B Benzamide compound, preparation method, application and pharmaceutical composition thereof 中国医学科学院药物研究所 2022-03-15 CN disclosed
US-20210047270-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2021-02-18 US disclosed
US-20210047270-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2021-02-18 US disclosed
EP-3747866-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2020-12-09 EP disclosed
EP-3747866-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2020-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12391647-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof JAK2, STAT3, STAT5A NAMPT 478/4885ALDH1A1 635/4885KDM4E 1559/4885
US-20230099912-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF JAK2, STAT3, STAT5A NAMPT 478/4885ALDH1A1 635/4885KDM4E 1559/4885
US-20210047270-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF JAK2, STAT3, STAT5A NAMPT 478/4885ALDH1A1 635/4885KDM4E 1559/4885
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof JAK2, STAT3, STAT5A NAMPT 478/4885ALDH1A1 635/4885KDM4E 1559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.